Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06409000 · ClinicalTrials.gov registry record
Evaluation of 3D Surface Scanning for Virtual-CT Based Radiation Therapy Treatment Planning
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 26
- Enrollment target
NCT06409000: Completed study, sponsored by Mayo Clinic.
NCT06409000 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06409000 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
This study evaluates if three dimensional (3D) surface images can be used instead of the standard computed tomography (CT) scans for treatment planning in electron radiation therapy. 3D scanning has previously been used by several groups to design patient-specific devices to be 3D printed, and as has shown excellent agreement with CT obtained surfaces. Using 3D surface imaging instead of x-ray based CT, benefits include: no ionizing radiation used to produce images, shorter time between patient consultation and treatment, and ability to produce and evaluate patient-specific devices for electron therapy earlier in the treatment planning process. This study may help researchers learn how 3D surface scanning may be used to produce a virtual CT image of patient surfaces, and accurately replace traditional planning CT for treatment planning of electron based radiation therapy.
Primary Outcome
The various three dimensional (3D) scans and CTs of the phantoms will be qualitatively assessed for agreement and accuracy to determine best practice, but there will be no statistical significance tested for. Will be conducted entirely on inanimate, plastic, anthropomorphic models (phantoms).
Interventions
- OTHER Electronic Health Record Review
- PROCEDURE Three-Dimensional Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2021-01-19 |
| Est. Completion | 2026-02-05 |
What the finished NCT06409000 record still lists
NCT06409000 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Electronic Health Record Review is the first listed.
NCT06409000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06409000 about?
NCT06409000 is a clinical study titled "Evaluation of 3D Surface Scanning for Virtual-CT Based Radiation Therapy Treatment Planning". This study evaluates if three dimensional (3D) surface images can be used instead of the standard computed tomography (CT) scans for treatment planning in electron radiation therapy. 3D scanning has previously been used by several groups to design patient-specific devices to be 3D printed, and as ha...
What is the current status of trial NCT06409000?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2021-01-19. Estimated completion is 2026-02-05.
What interventions are being tested in trial NCT06409000?
The interventions under investigation include: Electronic Health Record Review (OTHER), Three-Dimensional Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT06409000?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI